Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Acquired_by_Wockhardt_Ltd.
|
| gptkbp:awards |
Industry Awards
Innovation Awards |
| gptkbp:challenges |
Research Funding
Regulatory Compliance Market Competition |
| gptkbp:clinicalTrials |
Completed
Ongoing |
| gptkbp:collaborations |
Research Collaborations
Commercial Collaborations Joint_Ventures |
| gptkbp:communityEngagement |
Educational Initiatives
Health Awareness Programs Volunteer_Programs |
| gptkbp:employees |
500+
|
| gptkbp:financials |
Revenue Growth
Publicly Traded Profitability |
| gptkbp:focus |
Biopharmaceuticals
|
| gptkbp:founded |
2001
|
| gptkbp:futurePlans |
Expansion
New Product Launches Increased R&D Investment |
| gptkbp:headquarters |
gptkb:Germany
|
| https://www.w3.org/2000/01/rdf-schema#label |
Wockhardt Bio AG
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:innovation |
Process Optimization
Technology Transfer New_Drug_Development |
| gptkbp:market |
Global
Local Regional |
| gptkbp:operatesIn |
gptkb:Asia
gptkb:North_America Europe |
| gptkbp:parentCompany |
gptkb:Wockhardt_Ltd.
|
| gptkbp:partnerships |
Pharmaceutical Companies
Various Academic Institutions |
| gptkbp:products |
Vaccines
Monoclonal Antibodies Recombinant Proteins |
| gptkbp:regulatoryCompliance |
EMA_Approved
FDA_Approved |
| gptkbp:researchFocus |
Cancer
Infectious Diseases Autoimmune Diseases |
| gptkbp:services |
Contract Manufacturing
Research_and_Development |
| gptkbp:subsidiary |
gptkb:Wockhardt_Ltd.
|
| gptkbp:sustainabilityInitiatives |
Green Manufacturing
Energy Efficiency Programs Waste Reduction Programs |
| gptkbp:website |
www.wockhardt.com
|